Cancer Vaccines Market Revenue 2025 to 2034
Cancer Vaccines Market Revenue 2025 to 2034
The cancer vaccines market size is anticipated to grow from USD 11.38 billion in 2025 to USD 33.61 billion by 2034, with a compound annual growth rate (CAGR) of 11.44% during the forecast period from 2025 to 2034.
Report ID: 10116
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 11.38 Bn
Forecast Year,
USD USD 33.61 Bn
CAGR, 2025 -
11.44%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Cancer Vaccines Market Size Analysis
Cancer Vaccines Market Size By Type 2024 to 2034 (USD )
| Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Preventive Cancer Vaccines | 5.12 | 5.73 | 6.42 | 7.18 | 8.04 | 9.00 | 10.07 | 11.27 | 12.61 | 14.12 | 15.80 |
| Therapeutic Cancer Vaccines | 4.55 | 5.09 | 5.68 | 6.35 | 7.09 | 7.92 | 8.85 | 9.89 | 11.04 | 12.34 | 13.78 |
| Others | 1.71 | 1.86 | 2.04 | 2.22 | 2.42 | 2.64 | 2.88 | 3.13 | 3.41 | 3.71 | 4.03 |
Cancer Vaccines Market Size By Indication 2024 to 2034 (USD )
| Indication | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cervical Cancer | 3.98 | 4.43 | 4.92 | 5.47 | 6.07 | 6.75 | 7.50 | 8.33 | 9.26 | 10.29 | 11.43 |
| Prostate Cancer | 2.85 | 3.19 | 3.58 | 4.01 | 4.49 | 5.04 | 5.65 | 6.33 | 7.09 | 7.95 | 8.91 |
| Other Indications | 4.55 | 5.07 | 5.64 | 6.28 | 6.99 | 7.77 | 8.65 | 9.63 | 10.72 | 11.93 | 13.28 |
Cancer Vaccines Market Size By Technology 2024 to 2034 (USD )
| Technology | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Recombinant Cancer Vaccines | 3.41 | 3.82 | 4.27 | 4.77 | 5.34 | 5.97 | 6.67 | 7.46 | 8.34 | 9.32 | 10.42 |
| Viral Vector and DNA Cancer Vaccines | 2.85 | 3.18 | 3.56 | 3.98 | 4.46 | 4.99 | 5.58 | 6.24 | 6.98 | 7.81 | 8.74 |
| Whole-cell Cancer Vaccines | 2.85 | 3.15 | 3.49 | 3.87 | 4.28 | 4.74 | 5.25 | 5.82 | 6.44 | 7.13 | 7.90 |
| Others | 2.28 | 2.53 | 2.81 | 3.13 | 3.48 | 3.86 | 4.29 | 4.77 | 5.31 | 5.90 | 6.56 |
Cancer Vaccines Market Size By Distribution Channel 2024 to 2034 (USD )
| Distribution Channel | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 7.97 | 8.88 | 9.91 | 11.05 | 12.32 | 13.74 | 15.32 | 17.09 | 19.06 | 21.25 | 23.70 |
| Government Suppliers | 3.41 | 3.80 | 4.23 | 4.70 | 5.23 | 5.82 | 6.47 | 7.20 | 8.01 | 8.91 | 9.92 |
Cancer Vaccines Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 4.32 | 4.83 | 5.40 | 6.03 | 6.74 | 7.53 | 8.41 | 9.40 | 10.50 | 11.73 | 13.11 |
| Europe | 2.85 | 3.16 | 3.52 | 3.91 | 4.35 | 4.84 | 5.38 | 5.99 | 6.66 | 7.41 | 8.24 |
| Asia-Pacific | 2.28 | 2.55 | 2.85 | 3.20 | 3.58 | 4.01 | 4.49 | 5.03 | 5.63 | 6.30 | 7.06 |
| Latin America | 1.14 | 1.26 | 1.40 | 1.55 | 1.72 | 1.91 | 2.11 | 2.34 | 2.60 | 2.88 | 3.19 |
| Middle East & Africa | 0.80 | 0.88 | 0.96 | 1.06 | 1.16 | 1.27 | 1.39 | 1.53 | 1.68 | 1.84 | 2.02 |
Cancer Vaccines Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
